Herbert Virgin, EVP, Research & CSO at Vir Biotechnology, Inc. (VIR), sold 1,375 shares at $35.10 ($48K) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Scheduled sale ($48k) by EVP, Research & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2022-02-09 | $47K | — | Filing → |
| VIR | SELL | 2022-01-26 | $45K | — | Filing → |
| VIR | SELL | 2021-12-30 | $110K | — | Filing → |